Hanall Biopharma Co., Ltd.

Informe acción KOSE:A009420

Capitalización de mercado: ₩1.8t

Hanall Biopharma Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Seungwon Jeong

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO1.6yrs
Participación del CEOn/a
Permanencia media de la dirección1.6yrs
Promedio de permanencia en la Junta Directiva3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Hanall Biopharma Co., Ltd.'s (KRX:009420) 30% Share Price Surge Not Quite Adding Up

Oct 14
Hanall Biopharma Co., Ltd.'s (KRX:009420) 30% Share Price Surge Not Quite Adding Up

Calculating The Intrinsic Value Of Hanall Biopharma Co., Ltd. (KRX:009420)

Jun 26
Calculating The Intrinsic Value Of Hanall Biopharma Co., Ltd. (KRX:009420)

Getting In Cheap On Hanall Biopharma Co., Ltd. (KRX:009420) Is Unlikely

May 22
Getting In Cheap On Hanall Biopharma Co., Ltd. (KRX:009420) Is Unlikely

There May Be Underlying Issues With The Quality Of Hanall Biopharma's (KRX:009420) Earnings

Mar 13
There May Be Underlying Issues With The Quality Of Hanall Biopharma's (KRX:009420) Earnings

Introducing Hanall BiopharmaLtd (KRX:009420), The Stock That Zoomed 103% In The Last Five Years

Feb 12
Introducing Hanall BiopharmaLtd (KRX:009420), The Stock That Zoomed 103% In The Last Five Years

What Kind Of Investors Own Most Of Hanall Biopharma Co.,Ltd (KRX:009420)?

Jan 25
What Kind Of Investors Own Most Of Hanall Biopharma Co.,Ltd (KRX:009420)?

Hanall Biopharma Co.,Ltd's (KRX:009420) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 04
Hanall Biopharma Co.,Ltd's (KRX:009420) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Hanall BiopharmaLtd (KRX:009420) Is Growing Earnings But Are They A Good Guide?

Dec 14
Hanall BiopharmaLtd (KRX:009420) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Hanall BiopharmaLtd (KRX:009420) Is Well Worth Watching

Nov 21
Here's Why We Think Hanall BiopharmaLtd (KRX:009420) Is Well Worth Watching

CEO

Seungwon Jeong

1.6yrs

Permanencia

Sean Jeong, also known as Seungwon, M.D., MBA, serves as President & Director at Hanall Biopharma Co.,Ltd since 2021 and is its Co-Chief Executive Officer since April 2023 and was its Chief Executive Offic...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Sean Jeong
President1.6yrssin datossin datos
Su-Jin Park
Co-CEO, VP & Director1.6yrssin datos0.0037%
₩ 67.0m
Christopher Slavinsky
Chief Business Development & Legal Officerless than a yearsin datossin datos
Nam-Yong Cho
Senior Executive Director of Sales & Marketing and Senior Managing Directorno datasin datossin datos

1.6yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de A009420 no se considera experimentado ( 1.6 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Sean Jeong
President3.8yrssin datossin datos
Su-Jin Park
Co-CEO, VP & Director1.6yrssin datos0.0037%
₩ 67.0m
Sung-Hou Kim
Member of Scientific Advisory Boardno datasin datossin datos
Seung-Kook Park
Directorno datasin datos0.16%
₩ 3.0b
Jae-Ho Cheong
Member of Scientific Advisory Boardno datasin datossin datos
Yong Choi
Member of Scientific Advisory Boardno datasin datossin datos
Aekyung Kim
Member of Scientific Advisory Boardno datasin datossin datos
Young Shin
Member of Scientific Advisory Boardno datasin datossin datos
Jason Song
Member of Scientific Advisory Boardno datasin datossin datos
Jae-chun Yoon
Chairmanno datasin datossin datos
Hun Jung
Independent Director3.8yrssin datossin datos

3.8yrs

Permanencia media

Junta con experiencia: La junta directiva de A009420 se considera experimentada (3.8 años de antigüedad promedio).